Cerapedics Inc., a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair, today announced U.S. Food and Drug Administration (FDA) approval for an expansion to ...
Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval to be transferred from Sentynl Therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback